Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

RI-TE Radiation Imaging Technologies_media

We are looking for partnerships

medal 1
Ce profil est validé par 1 label.

Company

RI-TE Radiation Imaging Technologies

RI-TE Radiation Imaging Technologies_logo
14
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

RI-TE develops the best price/performance PET scanners for nuclear medical imaging, exploring three different segments: education & training, preclinical research (small animal imaging) and organ-specific clinical imaging.

Ílhavo, Aveiro, Portugal

Send a message

Anglais

RI-TE Radiation Imaging Technologies

Anglais

We're a spin-off from the Univ. of Aveiro developing innovative cost-efficient PET systems for nuclear medical imaging. PET scanners produce 3D images of labeled molecules inside the body, in-vivo and non-invasively, allowing evaluation of organ/tissue function. PET is the most sensitive technology to detect cancer, so it's very useful for diagnosis, staging and therapy monitorization.

Preclinical PET is important to study animal models of disease and is now a...

See more

We're a spin-off from the Univ. of Aveiro developing innovative cost-efficient PET systems for nuclear medical imaging. PET scanners produce 3D images of labeled molecules inside the body, in-vivo and non-invasively, allowing evaluation of organ/tissue function. PET is the most sensitive technology to detect cancer, so it's very useful for diagnosis, staging and therapy monitorization.

Preclinical PET is important to study animal models of disease and is now a critical tool for medical research, accelerating drug discovery and development. However, high complexity and cost of preclinical PET systems (> 0.5 m€) makes them unaffordable to most research centers, particularly in academia. In addition, there's no dedicated system for training.

RI-TE develops cost-effective innovative PET scanners, with a proprietary technology that produces high quality images with a much smaller number of detectors, reducing costs by +80%. Our mission is to democratize access to PET in 2 segments:

1) education & training (Universities & Health Schools) - with easyPET.3D

2) preclinical imaging (research centers, CROs) - with iPET

We now have a ready to market product (easyPET.3D) with impressive results and prooven capacity for biomedical studies in small mice, and we aim to build a more capable, advanced preclinical iPET scanner. In addition, our technology is scalable to build organ-specific PET scanners with up to 20 cm diameter field-of-view, e.g. for positron emission mammography.

  • 1

    Like

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1145 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected deep tech companies.
321 Members

Our history

Start in June 2015

  • June 2015

    ANJE Startup Accelerator prize: RI-TE was founded and obtained early BA investment

  • March 2016

    Patent Application (PCT/IB2016/051487), priority of 16/March/2015, filed in Germany and USA

  • October 2016

    PT2020 R&D project start (till 30/Nov. 2018) - 210k€ grant (non-dilutable)

  • November 2017

    Seal of Excellence, following SME Instrument phase 2 application

  • 2018

    EasyPET.3D ready to market. EIT Health Catapult semifinalist

to be continued ...